Antiangiogenic activity of 4-O-methylgallic acid from Canavalia gladiata, a dietary legume

Biochemical and Biophysical Research Communications

Volumn 330, Issue 4, 2005, Pages 1268-1274

  Jeon, Ki Suk ^a   Na, Hee Jun ^b   Kim, Young Myeong ^b   Kwon, Ho Jeong ^a  

^a Sejong University   (South Korea)

^b Kangwon National University   (South Korea)

Author keywords

4 O Methylgallic acid; Antiangiogenic agent; Canavalia gladiata

Indexed keywords

4 O METHYLGALLIC ACID; FIBROBLAST GROWTH FACTOR; GALLIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANAVALIA; CELL GROWTH; CELL INVASION; CONTROLLED STUDY; CYTOTOXICITY; DIET; ENDOTHELIUM CELL; HYPOXIA; LEGUME; MENTAL CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 17044413236     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.109     Document Type: Article

References (32)

1. J. Folkman Tumor angiogenesis: therapeutic implications N. Engl. J. Med. 285 1971 1182 1186
2. P. Carmeliet Blood vessels and nerves: common signals, pathways and diseases Nat. Rev. Genet. 4 2003 710 720
3. J. Folkman Tumor angiogenesis Adv. Cancer Res. 43 1985 175 203
4. D.A. Walsh Angiogenesis and arthritis Rheumatology (Oxford) 38 1999 103 112
5. A. Martin, M.R. Komada, and D.C. Sane Abnormal angiogenesis in diabetes mellitus Med. Res. Rev. 23 2003 117 145
6. T. Boehm, J. Folkman, T. Browder, and M.S. O'Reilly Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance Nature 390 1997 404 407
7. G. Saxena, A.R. McCutcheon, S. Farmer, G.H. Towers, and R.E.W. Hancock Antimicrobial constituents of Rhus glabra J. Ethnopharmacol. 42 1994 95 99
8. W.M. Davis, N.S. Hatoum, and J.H. Khalsa Toxic interaction between narcotic analgesics and inhibitors of catechol-O-methyltransferase Toxicology 14 1979 217 227
9. B. Nikodejevic, S. Senoh, J.W. Daly, and C.R. Creveling Catechol-O-methyltransferase. II.A new class of inhibitors of catechol-o-methyltransferase; 3,5-dihydroxy-4-methoxybenzoic acid and related compounds J. Pharmacol. Exp. Therapeutics 174 1970 83 93
10. B. Nikodijevic, T. Trajkov, E. Glavas, and D. Vetadzokoska Inhibition of noradrenaline biosynthesis and the level of blood pressure in spontaneously hypertensive rats and metacorticoid rats Physiol. et Pharmacol. Acta 7 1971 293 298
11. B. Vailhé, D. Vittet, and J.J. Feige In vitro models of vasculogenesis and angiogenesis Lab. Invest. 81 2001 439 452
12. H.J. Jung, H.B. Lee, C.H. Lim, C.J. Kim, and H.J. Kwon Cochlioquinone A1, a new anti-angiogenic agent from Bipolaris zeicola Bioorg. Med. Chem. 11 2003 4743 4747
13. J.S. Shim, D.H. Kim, H.J. Jung, J.H. Kim, D. Lim, S.K. Lee, K.W. Kim, J.W. Ahn, J.S. Yoo, J.R. Rho, J. Shin, and H.J. Kwon Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation Bioorg. Med. Chem. 10 2002 2439 2444
14. Y. Cao, and R. Cao Angiogenesis inhibited by drinking tea Nature 398 1999 381
15. D. Ribatti, A. Vacca, and M. Presta The discovery of angiogenic factors: a historical review Gen. Pharmacol. 35 2000 227 231
16. R.T. Poon, S.T. Fan, and J. Wong Clinical implications of circulating angiogenic factors in cancer patients J. Clin. Oncol. 19 2001 1207 1225
17. Y. Shing, J. Folkman, R. Sullivan, C. Butterfield, J. Murray, and M. Klagsbrun Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor Science 223 1984 1296 1299
18. A. Bikfalvi, S. Klein, G. Pintucci, and D.B. Rifkin Biological roles of fibroblast growth factor-2 Endocr. Rev. 18 1997 26 45
19. D. Hanahan, and J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 86 1996 353 364
20. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309
21. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
22. K.J. Kim, B. Li, J. Winer, M. Armanini, N. Gillett, H.S. Phillips, and N. Ferrara Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature 362 1993 841 844
23. Y. Nonaka, H. Iwagaki, T. Kimura, S. Fuchimoto, and K. Orita Effect of reactive oxygen intermediates on the in vitro invasive capacity of tumor cells and liver metastasis in mice Int. J. Cancer 54 1993 983 986
24. M.R. Abid, Z. Kachra, K.C. Spokes, and W.C. Aird NADPH oxidase activity is required for endothelial cell proliferation and migration FEBS Lett. 486 2000 252 256
25. M.R. Abid, J.C. Tsai, K.C. Spokes, S.S. Deshpande, K. Irani, and W.C. Aird Vascular endothelial growth factor induces manganese-superoxide dismutase expression in endothelial cells by a Rac1-regulated NADPH oxidase-dependent mechanism FASEB J. 15 2001 2548 2550
26. R. Colavitti, G. Pani, B. Bedogni, R. Anzevino, S. Borrello, J. Waltenberger, and T. Galeotti Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR J. Biol. Chem. 277 2002 3101 3108
27. M. Ushio-Fukai, Y. Tang, T. Fukai, S.I. Dikalov, Y. Ma, M. Fujimoto, M.T. Quinn, P.J. Pagano, C. Johnson, and R.W. Alexander Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis Circ. Res. 91 2002 1160 1167
28. C.P. LeBel, H. Ischiropoulos, and S.C. Bondy Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress Chem. Res. Toxicol. 5 1992 227 231
29. Y.D. Jung, and L.M. Ellis Inhibition of tumour invasion and angiogenesis by epigallocatachin gallate (EGCG), a major component of green tea Int. J. Exp. Pathol. 82 2001 309 316
30. H. Tachibana, K. Koga, Y. Fujimura, and K. Yamada A receptor for green tea polyphenol EGCG Nat. Struct. Mol. Biol. 11 2004 380 381
31. J.S. Shim, J.H. Kim, H.Y. Cho, Y.N. Yum, S.H. Kim, H.J. Park, B.S. Shim, S.H. Choi, and H.J. Kwon Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin Chem. Biol. 10 2003 695 704
32. Y. Cao, Z.D. Fu, F. Wang, H.Y. Liu, and R. Han Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants J. Asian Nat. Prod. Res. 7 2005 205 213